ArticleJournal of molecular neuroscience : MN2026
Mitoxyperiosis Defines a Monocyte-driven Inflammatory Endotype in Ischemic Stroke: Multi-cohort Transcriptomic and Single-cell CITE-seq Analysis.
Article in Journal of molecular neuroscience : MN, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Mitoxyperiosis is a recently identified form of regulated cell death driven by mitochondrial oxidative membrane rupture, but its role in ischemic stroke remains unknown. We investigated whether mitoxyperiosis-associated transcriptional activity identifies an inflammatory endotype and computationally prioritized candidate regulators. We analyzed peripheral-blood transcriptomes from GSE16561 (39 patients, 24 controls). Molecular subtypes were evaluated in GSE37587 (34 patients with paired Baseline and Follow-Up samples) and GSE58294 (23 patients sampled at 3, 5, and 24 h). CITE-seq data from GSE285659 (74,714 cells) were used for cellular localization. After adjustment for age and sex, 11 of 38 mitoxyperiosis-related genes were upregulated in ischemic stroke, and the pathway score was higher than in controls (P = 0.038; unadjusted Cohen's d = 0.80). Consensus clustering identified Mito-high (n = 12) and Mito-low (n = 27) subtypes (d = 2.51). Mito-high showed higher pyroptosis, ferroptosis, and necroptosis signature scores and lower expression of 11 of 12 differentially expressed immune checkpoints. All 50 subtype-associated genes were directionally concordant in GSE37587. In GSE58294, the inter-subtype effect size increased from 3 to 24 h (d = 0.83 to 1.20). Mito-high cells comprised 0.32% of profiled cells, of which 92.8% were monocytes. Connectivity mapping and target-pathway correlation analyses prioritized EZH2 and HDAC2 as candidate regulators. Mitoxyperiosis-associated transcriptional activity characterizes a monocyte-enriched inflammatory endotype in ischemic stroke. The Mito-high/Mito-low classification provides a molecular framework for investigating subtype-associated immune features and candidate epigenetic regulators.
Indexed as
Identifiers
42842152What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.